Citation Tools
PDFClinical/translational cancer immunotherapy
Original research
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study